Glucocorticoid receptor expression in inflammatory bowel disease: evidence for a mucosal down‐regulation in steroid‐unresponsive ulcerative colitis

Abstract

Summary Background : Glucocorticoids (GC) play a major role in the attenuation of inflammation. Glucocorticoid receptor (GR) expression is an important determinant of steroid sensitivity. Aims : To investigate whether GR mRNA expression is altered in inflammatory bowel disease, and whether GR mRNA expression correlates with disease activity and may predict response to GC therapy. Methods : Mucosal biopsies were taken from 33 patients with ulcerative colitis, 21 with Crohn's disease and 11 controls. Peripheral blood mononuclear cells were isolated from 24 ulcerative colitis and 18 Crohn's disease patients and 11 controls. GR mRNA was measured by quantitative reverse transcriptase polymerase chain reaction (RT‐PCR), and correlated to endoscopic findings, clinical activity and outcome of GC therapy. In a subset of subjects GR localisation was shown by immunohistochemistry. Results : In patients with inflammatory bowel disease GR expression was not different from controls. However, GR was decreased in biopsies from ulcerative colitis patients with impaired GC response. The inhibitory subtype GRβ was expressed 100–1000 times lower than GRα. GR immunoreactivity was identified in immune and epithelial cells except for colonic crypts. Conclusion : In inflammatory bowel disease systemic and mucosal GR mRNA expression is not altered. However, in ulcerative colitis patients, low mucosal GR expression may predict the outcome of GC therapy. The low expression of GRβ challenges its role in steroid refractoriness in inflammatory bowel disease.

Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients

“…Currently, we do not have any useful marker for predicting the future response to LCAP, comparable the expression of the glucocorticoid receptor on leukocytes or the local mucosa, which has been suggested as a possible marker for determining the steroid response. 25 Our results show that the clinical response to LCAP was associated with modulations of population and/or platelet functions, especially after the first LCAP.…”

Negative Inotropy of the Gastric Proton Pump Inhibitor Pantoprazole in Myocardium From Humans and Rabbits

“…Quantitative reverse transcription polymerase chain reaction (RT-PCR) was performed by real-time PCR as described earlier. 19 Primer pairs for H ϩ /K ϩ -ATPase and ␤-actin are summarized in the Table. Each sample was analyzed in duplicate. The investigated number of cDNA molecules was related to ␤-actin cDNA molecules detected in the same sample to normalize for the quantity of RNA extracted and the efficiency of cDNA synthesis.…”

“…The relative expression was then calculated as described. 19 Developed Tension (mN/mm²) (Figures 1 and 4), or the Tukey test was used ( Figure 6). The authors had full access to and take full responsibility for the integrity of the data.…”

Clinical, Biological, and Laboratory Parameters as Predictors of Severity of Clinical Outcome and Response to Anti–TNF–Alpha Treatment in Ulcerative Colitis

“…Although the leukocyte recruitment by adhesion molecules plays a role in the initiation and progression of the disease, there is little documentation of their roles as biomarkers. The gene expression of ICAM-1 is elevated in UC but was not correlated with response to steroids (Raddatz et al, 2004). In the same study low expression of the glucocorticoid receptor was correlated to non-response.…”